Activity value 94International Buyer&Supplier,Last transaction date:
2026-05-19Address: 750 corporate dr mahwah, new jersey 07430-2009 united states
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for glenmark pharmaceuticals inc. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1235 transactions, with a transaction quantity of 29928109.41 and a transaction weight of 1446979.22.
YearTransactionsQuantityWeight
20256896175621971.694319549.57
2026123529928109.411446979.22
Bill of lading data
<
1/15
>
Trade date
2026/05/19
B/L No.
yasvbom0080139
Suppliers
glenmark pharmaceuticals inc.
Buyers
glenmark pharmaceuticals inc.
POLs
53313, jawaharlal nehru
PODs
4601, new york/newark area, newark, nj
Product description
41 PACKAGES 1305 CARTONS PHARMACEUTICALS AS UNDER INDOMETHACIN CAP 50MG 100 NDC CODE68462 030201 FDA PRODUCT CODE NO. 62 G C E 42 H. T.S NO. 3004.90.92.40 ANDA NO.91276 THERAPEUTI CE USE ANTIINFLAMATORY ACAMPROSATE CALCIUM D R TAB 333MG 180 NDC CODE68462043518 FDA PRODUCT CODE NO. 60 T C C 99 H. T. S NO. 3004.90.9 2.40 ANDA NO.202229 THERAPEUTICE USE FOR TRE ATING ALCOHOL DEPENDENCE MUPIROCIN OINT 2 22 GM NDC CODE68462018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T. S NO. 3004.90.92.45 ANDA NO.90480 THERAPEUTICE USE ANTIBACTERIAL NORET H ACEEE TAB 10.02MG 63 NDC CODE68462013281 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO. 3006.60.00.00 ANDA NO.206969 THERAPEUTICE USE S ECONDARY AMENORRHEAENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL CUSTOM INVOIC E NO. F22752000066 DT. 08.04.2026 F22752000067 DT. 08.04.2026 F22752000064 DT. 08.04.2026 F22752000065 DT. 08.04.2026 SBILL NO2253083 DT 09APR2026 SBILL NO2247602 DT 09APR2026 SBILL NO2247608 DT 09APR2026 SBILL NO2253136 DT 09APR2026 GROSS WT.7791.960 KGS NET WT.6132.70 0 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERA TURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXXXXX Expand
Trade date
2026/05/09
B/L No.
yasvbom0080007
Suppliers
gland pharma
Buyers
glenmark pharmaceuticals inc.
POLs
53313, jawaharlal nehru
PODs
4601, new york/newark area, newark, nj
Product description
PART OF FCL 10 PACKAGES 373 CARTONS PHARMACE UTICALS AS UNDER 8.4 SODIUM BICARBONATE INJE CTION USP 50 MEQ50 ML (1 MEQML) (25S PACK) NDC CODE 68462095165 HTS 3004.90.9266 FDA CODE 65RCK18 ANDA 219701 COMMERCIAL CUSTOM INV OICE NO. INVXXXXXXXXX DT. 20.03.2026 SBILL N O 1689159 DT 21MAR2026 GROSS WT.4987.035 KGS NET WT.1945.568 KGS 02 DATA LOGGERS HUMIDIT Y65 SET TEMPERATURE 18 DEGREES TEMPERATURE R ANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 GLENMARK PHARMACEUTICALS INC. USA XXXXXXXXXXX Expand
Trade date
2026/05/08
B/L No.
maeu268741623
Suppliers
glenmark pharmaceuticals inc.
Buyers
glenmark pharmaceuticals inc.
POLs
52330, salalah
PODs
4601, new york/newark area, newark, nj
Product description
41 PACKAGES 1891 CARTONS PHARMACEUTICALS AS UNDER HAILEY FE 120 TAB 1MG20MCG75MG 84 NDC C ODE68462041929 FDA PRODUCT CODE NO. 65 J D A 25 H. T. S NO. 3006.60.00.00 ANDA NO.206597 THERAPEUTICE USE HORMONE MEDICATION IS USED TOPREVENT PREGNANCY HEATHER TAB 0.35MG 84 NDC CODE68462030329 FDA PRODUCT CODE NO. 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO.90454 THERAPEUTICE USE PREVENTION OF PREGNANCY. NO RETHINDRONE ACE TAB 5MG 50 NDC CODE68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.3004.39.00.50 ANDA NO.91090 THERAPEUTICE USE SECONDARY AMENORRHEAENDOMETRIOS IS AND ABNOR MAL UTERINE BLEEDING HAILEY 1.530 TAB 1.5MG3 0MCG 63 NDC CODE68462050481 FDA PRODUCT CODE NO. 65 J D A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 209297 THERAPEUTICE USE CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL CUSTOM INVO ICE NO. F22652006851 DT. 31.03.2026 F22652006866 DT. 31.03.2026 F22652006869 DT. 31.03.2026 F22752000000 DT. 01.04.2026 SBILL NO 2034852 DT 01APR2026 SBILL NO 2035092 DT 01APR2026 SBILL NO 2034764 DT 01APR2026 SBILL NO 206466 6 DT 02APR2026 GROSS WT.7354.790 KGS NET WT. 5793.240 KGS 10 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXX DU PORT 2 NEUCHATEL 2000 XXXXXXXXXXX Expand
glenmark pharmaceuticals inc. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical,cap.
According to the 52wmb.com global trade database, as of 2026-05-19, the company has completed 382275 international trades,
with its main trading regions covering india,other,united states etc.
The core products include HS30049099,HS30049034,HS30049081 etc,
often transported via new york,port newark nj, port sahar air cargo acc inbom4 etc,
and its main trading partners are glenmark pharmaceuticals inc.,lageen tuboplast ltd,glenmark generics ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glenmark pharmaceuticals inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.